000			02344 a2200661 4500
005			20250516030053.0
264		0	_c20110927
008			201109s 0 0 eng d
022			_a1399-0020
024	7		_a10.1016/j.ijom.2011.02.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aKatz, J
245	0	0	_aGenetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. _h[electronic resource]
260			_bInternational journal of oral and maxillofacial surgery _cJun 2011
300			_a605-11 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAryl Hydrocarbon Hydroxylases _xgenetics
650	0	4	_aBone Density Conservation Agents _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aCollagen Type I _xgenetics
650	0	4	_aCollagen Type I, alpha 1 Chain
650	0	4	_aCytochrome P-450 CYP2C8
650	0	4	_aDiphosphonates _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGene Frequency _xgenetics
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aInjections, Intravenous
650	0	4	_aJaw Diseases _xchemically induced
650	0	4	_aMale
650	0	4	_aMatrix Metalloproteinase 2 _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aOsteonecrosis _xchemically induced
650	0	4	_aOsteopontin _xgenetics
650	0	4	_aOsteoprotegerin _xgenetics
650	0	4	_aPamidronate
650	0	4	_aPolymorphism, Genetic _xgenetics
650	0	4	_aPolymorphism, Single Nucleotide _xgenetics
650	0	4	_aReceptor Activator of Nuclear Factor-kappa B _xgenetics
650	0	4	_aRisk Factors
650	0	4	_aSmoking
650	0	4	_aTime Factors
650	0	4	_aTumor Necrosis Factor-alpha _xgenetics
650	0	4	_aZoledronic Acid
700	1		_aGong, Y
700	1		_aSalmasinia, D
700	1		_aHou, W
700	1		_aBurkley, B
700	1		_aFerreira, P
700	1		_aCasanova, O
700	1		_aLangaee, T Y
700	1		_aMoreb, J S
773	0		_tInternational journal of oral and maxillofacial surgery _gvol. 40 _gno. 6 _gp. 605-11
856	4	0	_uhttps://doi.org/10.1016/j.ijom.2011.02.002 _zAvailable from publisher's website
999			_c20668818 _d20668818